AN IN SILICO ANALYSIS OF FOLLICULIN AND FOLLICULIN INTERACTING PROTEINS RESPONSIBLE FOR SKIN TUMORS AND BIRT HOGG DUBÃ‰ SYNDROME.
Birtâ€“Hoggâ€“DubeÂ´ (BHD) syndrome is an inherited and autosomal disease characterized by skin and kidney tumors, as well as cystic lung disease, which results from mutation in BHD gene / FLCN gene. The product of FLCN gene is folliculin protein which has been implicated in numerous signalling pathways like mTOR, AMPK signalling, HIF signalling, TGF-Î² signalling and the JAK-STAT signalling pathway. From literature it was clear that there were two major consequences of mutated folliculin. First is hindrance in formation of FLCN, FNIP1 and FNIP2 complex, which ultimately interacts with TGF-Î² protein of TGF-Î² signalling pathway and inactivates tumor suppression function of that pathway. The other major consequence is activation of HIF1A. From HIF-reporter cell-based screening studies of a natural product-like chemical library it is suggested that KC7F2 is an inhibitor of HIF1A. Thus here we have focused on another inducible factor HIF2A interaction with KC7F2 to carry out insilico analysis. A previous study also suggests ability of TSA to reverse the biological and molecular defects of BHD cells but they have also suggested that further work will be needed to elucidate the nature of these effects. So we have carried out the work to study the nature of these effects and the mode of interaction between TSA and TGF-Î² protein. We found that TSA binds with TGF-Î² protein at same site where the non-mutated folliculin protein was binding and thus the TGF-Î² protein works normally, as a result anti-proliferation will takes place via p15 protein and ultimately the tumor suppression will takes place.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).